Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. / Høiby, N; Krogh Johansen, H; Moser, C; Song, Z; Ciofu, O; Kharazmi, A.

In: Microbes and Infection, Vol. 3, No. 1, 2001, p. 23-35.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Høiby, N, Krogh Johansen, H, Moser, C, Song, Z, Ciofu, O & Kharazmi, A 2001, 'Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.', Microbes and Infection, vol. 3, no. 1, pp. 23-35.

APA

Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001). Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes and Infection, 3(1), 23-35.

Vancouver

Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes and Infection. 2001;3(1):23-35.

Author

Høiby, N ; Krogh Johansen, H ; Moser, C ; Song, Z ; Ciofu, O ; Kharazmi, A. / Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. In: Microbes and Infection. 2001 ; Vol. 3, No. 1. pp. 23-35.

Bibtex

@article{0d2441f0ba2111ddae57000ea68e967b,
title = "Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.",
abstract = "The biofilm mode of growth is the survival strategy of environmental bacteria like Pseudomonas aeruginosa. Such P. aeruginosa biofilms also occur in the lungs of chronically infected cystic fibrosis patients, where they protect the bacteria against antibiotics and the immune response. The lung tissue damage is due to immune complex mediated chronic inflammation dominated by polymorphonuclear leukocytes releasing proteases and oxygen radicals.",
author = "N H{\o}iby and {Krogh Johansen}, H and C Moser and Z Song and O Ciofu and A Kharazmi",
note = "Keywords: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Cystic Fibrosis; Drug Resistance, Microbial; Endopeptidases; Humans; Inflammation; Lung; Neutrophils; Pseudomonas Infections; Pseudomonas aeruginosa",
year = "2001",
language = "English",
volume = "3",
pages = "23--35",
journal = "Microbes and Infection",
issn = "1286-4579",
publisher = "Elsevier Masson",
number = "1",

}

RIS

TY - JOUR

T1 - Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

AU - Høiby, N

AU - Krogh Johansen, H

AU - Moser, C

AU - Song, Z

AU - Ciofu, O

AU - Kharazmi, A

N1 - Keywords: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Cystic Fibrosis; Drug Resistance, Microbial; Endopeptidases; Humans; Inflammation; Lung; Neutrophils; Pseudomonas Infections; Pseudomonas aeruginosa

PY - 2001

Y1 - 2001

N2 - The biofilm mode of growth is the survival strategy of environmental bacteria like Pseudomonas aeruginosa. Such P. aeruginosa biofilms also occur in the lungs of chronically infected cystic fibrosis patients, where they protect the bacteria against antibiotics and the immune response. The lung tissue damage is due to immune complex mediated chronic inflammation dominated by polymorphonuclear leukocytes releasing proteases and oxygen radicals.

AB - The biofilm mode of growth is the survival strategy of environmental bacteria like Pseudomonas aeruginosa. Such P. aeruginosa biofilms also occur in the lungs of chronically infected cystic fibrosis patients, where they protect the bacteria against antibiotics and the immune response. The lung tissue damage is due to immune complex mediated chronic inflammation dominated by polymorphonuclear leukocytes releasing proteases and oxygen radicals.

M3 - Journal article

C2 - 11226851

VL - 3

SP - 23

EP - 35

JO - Microbes and Infection

JF - Microbes and Infection

SN - 1286-4579

IS - 1

ER -

ID: 8744930